基于CT的Leiden评分在预测糖尿病患者疑似冠心病主要不良心血管事件中优于Confirm评分
该单中心前瞻性队列研究纳入1241例疑似冠心病的糖尿病患者,计算基于CCTA的Leiden与Confirm评分并随访主要不良心血管事件(MACE)。中位随访31个月,Leiden评分与MACE风险显著相关(5-20分HR 2.37,>20分HR 4.39),而Confirm评分无统计学意义;Leiden评分AUC 0.840优于Confirm评分0.777(p<0.001)。
要点
- 对糖尿病疑似冠心病患者,CCTA的Leiden评分可有效分层MACE风险,优于Confirm评分。
- Leiden评分>20者MACE风险是<5者的4.39倍,应重点提示临床。
- Confirm评分在本队列中与MACE无显著独立关联,不建议单独用于风险分层。
核心结论
- 基于CCTA的风险评分可用于糖尿病患者疑似冠心病的可靠心血管风险预测,Leiden评分在预测MACE方面优于Confirm评分。
研究设计与样本
- 单中心前瞻性队列研究连续纳入1241例因疑似冠心病转诊CCTA的糖尿病患者(男性54.1%,年龄60.2±10.4岁),2015-2017年入组。
- 计算Leiden评分(分层<5、5-20、>20)和Confirm评分(分层<14.3、14.3-19.5、>19.5),采用Cox模型和Kaplan-Meier法分析,并比较中位随访时间的AUC。
诊断标准与关键数值
- Leiden评分分层:<5(参照)、5-20、>20;Confirm评分分层:<14.3(参照)、14.3-19.5、>19.5。
- Leiden评分5-20的HR为2.37(95%CI 1.53-3.69,p<0.001),>20的HR为4.39(95%CI 2.40-8.01,p<0.001)。
- Confirm评分与MACE风险无统计学显著关联;Leiden评分AUC 0.840,Confirm评分AUC 0.777(p<0.001)。
临床应用与阅片要点
- 对糖尿病疑似冠心病患者,CCTA报告可计算Leiden评分辅助风险分层,>20分提示高MACE风险。
- Confirm评分在本队列中预测价值有限,不应单独用于该类患者的风险分层。
局限性
- 单中心前瞻性队列研究,结果外推需多中心验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Evidence supports the efficacy of coronary computed tomography angiography (CCTA)-based risk scores in cardiovascular risk stratification of patients with suspected coronary artery disease (CAD). We aimed to compare two CCTA-based risk score algorithms, Leiden and Confirm scores, in patients with diabetes mellitus (DM) and suspected CAD.
MATERIALS AND METHODS: This single-center prospective cohort study consecutively included 1241 DM patients (54.1% male, 60.2 ± 10.4 years) referred for CCTA for suspected CAD in 2015-2017. Leiden and Confirm scores were calculated and stratified as < 5 (reference), 5-20, and > 20 for Leiden and < 14.3 (reference), 14.3-19.5, and > 19.5 for Confirm. Major adverse cardiovascular events (MACE) were defined as the composite outcomes of cardiovascular death, nonfatal myocardial infarction (MI), stroke, and unstable angina requiring hospitalization. The Cox model and Kaplan-Meier method were used to evaluate the effect size of the risk scores on MACE. The area under the curve (AUC) at the median follow-up time was also compared between score algorithms.
RESULTS: During a median follow-up of 31 months (interquartile range, 27.6-37.3 months), 131 of MACE were recorded, including 17 cardiovascular deaths, 28 nonfatal MIs, 64 unstable anginas requiring hospitalization, and 22 strokes. An incremental incidence of MACE was observed in both Leiden and Confirm scores, with an increase in the scores (log-rank p < 0.001). In the multivariable analysis, compared with Leiden score < 5, the hazard ratios for Leiden scores of 5-20 and > 20 were 2.37 (95% confidence interval [CI]: 1.53-3.69; p < 0.001) and 4.39 (95% CI: 2.40-8.01; p < 0.001), respectively, while the Confirm score did not demonstrate a statistically significant association with the risk of MACE. The Leiden score showed a greater AUC of 0.840 compared to 0.777 for the Confirm score (p < 0.001).
CONCLUSION: CCTA-based risk score algorithms could be used as reliable cardiovascular risk predictors in patients with DM and suspected CAD, among which the Leiden score outperformed the Confirm score in predicting MACE.
引用
- Liu, Ding, Dou, et al. CT-Based Leiden Score Outperforms Confirm Score in Predicting Major Adverse Cardiovascular Events for Diabetic Patients with Suspected Coronary Artery Disease. Korean J Radiol. 2022. PMID: 36098342. doi:10.3348/kjr.2022.0115
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。